📰 Industry Classification Benchmark News
Page 7 - Industry Classification Benchmark News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Industry Classification Benchmark. Real-time updates on events, politics, business and more.
December 21, 2023
Wealthcare Advisory Partners LLC increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 5.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,128 shares of the financial services provider’s stock after acquiring an additional […]
December 20, 2023
Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the company was added to the NASDAQ Biotech Index , effective prior to market open...
December 20, 2023
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that the company was added to the NASDAQ Biotech Index (Nasdaq: NBI), effective prior to market open on Monday, December 18, 2023.The NASDAQ Biotechnology Inde...
December 17, 2023
Key takeaways The healthcare sector is coming off a year of underperformance as COVID sales declined, bond yields rose, and new weight-loss therapies caused...
December 15, 2023
Activest Wealth Management purchased a new position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 474 shares of the financial services provider’s stock, valued at approximately $58,000. A number of other institutional investors also recently made changes to […]
December 14, 2023
Bay Rivers Group trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 8.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,759 shares of the financial services provider’s stock after selling 248 shares during the period. […]
November 28, 2023
Kestra Advisory Services LLC reduced its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 11.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 39,395 shares of the financial services provider’s stock after selling 4,991 shares during the period. Kestra […]
November 17, 2023
Meitav Investment House Ltd. reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 0.7% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,375 shares of the financial services provider’s stock after selling 102 shares during the quarter. Meitav […]
November 15, 2023
Nwam LLC boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 11.2% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 50,847 shares of the financial services provider’s stock after buying an additional 5,101 shares during the period. Nwam LLC owned […]
November 9, 2023
Haverford Trust Co lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 7.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,517 shares of the financial services provider’s stock after selling 363 shares during the period. Haverford Trust Co’s holdings in […]